Psych MEQs / SAQs · Specialty psychiatry — sleep medicine interface
Chronic insomnia disorder with residual depression and long-term Z-drug use (MEQ)
FRANZCP-style MEQ on insomnia disorder: CBT-I first-line, Z-drug dependence, OSA screen, occupational sleepiness, depression bidirectional risk. FRANZCP-primary, globally tagged.
On this page & tools
Target exams
Model answer
Reveal model answer
(i) Formulation. Chronic insomnia disorder (onset and maintenance, multi-year course, frequency, daytime impairment) comorbid with residual MDD. Maintaining factors: alcohol (shortens latency, fragments architecture), long-term zopiclone with tolerance/dependence pattern, possible OSA (BMI, snoring), and likely Spielman perpetuating behaviours (extended time in bed, sleep effort). Differentials: OSA vs pure psychiatric insomnia, circadian delay less likely from stem, substance-related sleep disruption, medical causes not yet excluded, residual depression driving middle insomnia. Treat insomnia as a disorder even when comorbid.[1][6]
(ii) Assessment/investigations. Structured sleep history and 1–2 week diary; substances; suicide risk; driving risk (near-miss is a red flag). Partner history for apnoeas. ISI for severity/response; ESS if sleepiness/driving is the issue. STOP-BANG-type OSA screen. Review medications and OTCs. Consider sleep study given OSA probability; do not delay CBT-I solely for PSG waitlists. Baseline mood scales; medical labs as indicated (TFT, FBC, glucose).[1][2]
(iii) Stepped plan. Psychoeducation; stop alcohol as hypnotic. CBT-I first-line — stimulus control, sleep restriction with occupational safety planning, cognitive therapy, relaxation, education; face-to-face or digital per access.[1][2][3][6] Optimise depression treatment in parallel (not instead of CBT-I). Hypnotic deprescribing: shared plan to taper zopiclone, avoid escalation, do not replace with open-ended quetiapine for primary insomnia. Short-term bridge only if needed during CBT-I with exit criteria. Sedating antidepressant only if depression warrants, knowing hangover/weight/OSA risks. Morin-type teaching: meds may help short-term; CBT-I durability is superior long-term.[1][8]
(iv) OSA and work. Refer sleep medicine; weight management; alcohol reduction. Pending assessment, discuss temporary work/driving safety after near-miss, OHS liaison as appropriate, jurisdiction fitness-to-drive principles. CPAP if moderate–severe OSA confirmed — support adherence and mood in parallel.[6]
(v) Depression/suicide evidence. Longitudinal meta-analysis shows insomnia predicts incident depression; sleep disturbance associates with suicidal ideation/attempt/death — document SI carefully and treat sleep as part of risk reduction, not optional comfort care.[4][5]
Common errors
- Only increasing zopiclone dose.
- Ignoring OSA and alcohol.
- Claiming CBT-I is optional lifestyle advice or “just hygiene.”
- Discharging without occupational near-miss plan.
- Treating insomnia as purely secondary and waiting for full mood remittance before any sleep treatment. [1][2][5]
Examiner notes
Award marks for simultaneous CBT-I + depression optimisation + OSA pathway + deprescribing + risk. Full marks require evidence-linked first-line CBT-I (ACP/AASM/Europe) and suicide/depression bidirectionality. [1][2][4]
References
- [1]Qaseem A, Kansagara D, Forciea MA, et al. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians Ann Intern Med, 2016.PMID 27136449
- [2]Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline J Clin Sleep Med, 2021.PMID 33164742
- [3]Trauer JM, Qian MY, Doyle JS, et al. Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis Ann Intern Med, 2015.PMID 26054060
- [4]Baglioni C, Battagliese G, Feige B, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies J Affect Disord, 2011.PMID 21300408
- [5]Pigeon WR, Pinquart M, Conner K Meta-analysis of sleep disturbance and suicidal thoughts and behaviors J Clin Psychiatry, 2012.PMID 23059158
- [6]Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia J Sleep Res, 2017.PMID 28875581
- [7]Glass J, Lanctot KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits BMJ, 2005.PMID 16284208
- [8]Morin CM, Vallieres A, Guay B, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial JAMA, 2009.PMID 19454639